Breaking News, Promotions & Moves

AstraZeneca Taps Rick Suarez as US President & Head of the US Biopharmaceuticals Business Unit

Suarez will lead the execution of the company’s $50 billion U.S. research, development and manufacturing investment.

Author Image

By: Charlie Sternberg

Associate Editor

AstraZeneca has named Rick R. Suarez as Senior Vice President, U.S. President and Head of the U.S. Biopharmaceuticals Business Unit. Suarez will lead the execution of the company’s previously announced $50 billion U.S. research, development and manufacturing investment, including construction of a $4.5 billion manufacturing facility in Virginia, AstraZeneca’s largest single manufacturing investment globally. He will also have full responsibility for AstraZeneca’s US Biopharmaceuticals orga...

Continue reading this story and get 24/7 access to Contract Pharma for FREE


Already a subscriber? Sign in

Keep Up With Our Content. Subscribe To Contract Pharma Newsletters